Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuet-Kin Leung

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Neoplasia (New York, N.Y.)|November 30, 2006
Apigenin suppresses cancer cell growth through ERbetaPaul Mak, Yuet-Kin Leung, Wan-Yee Tang, et al.
Cancer Research|May 4, 2005
Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesisYuet-Kin Leung, Kin-Mang Lau, James Mobley, et al.
The Journal of Biological Chemistry|July 17, 2013
Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent mannerMing-Tsung Lee, Yuet-Kin Leung, Irving Chung, et al.
Neoplasia (New York, N.Y.)|June 8, 2006
ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalkYuet-Kin Leung, Ying Gao, Kin-Mang Lau, et al.
Neoplasia (New York, N.Y.)|December 17, 2013
Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12Ming-Tsung Lee, Shuk-Mei Ho, Pheruza Tarapore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2019
NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuriesTilak Khanal, Yuet-Kin Leung, Wang Jiang, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Steroids|April 3, 2012
Estrogen receptor-beta and breast cancer: translating biology into clinical practiceYuet-Kin Leung, Ming-Tsung Lee, Hung-Ming Lam, et al.
ILAR Journal|June 8, 2013
Environmental epigenetics and its implication on disease risk and health outcomesShuk-Mei Ho, Abby Johnson, Pheruza Tarapore, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Neoplasia (New York, N.Y.)|November 30, 2006
Apigenin suppresses cancer cell growth through ERbetaPaul Mak, Yuet-Kin Leung, Wan-Yee Tang, et al.
Cancer Research|May 4, 2005
Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesisYuet-Kin Leung, Kin-Mang Lau, James Mobley, et al.
The Journal of Biological Chemistry|July 17, 2013
Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent mannerMing-Tsung Lee, Yuet-Kin Leung, Irving Chung, et al.
Neoplasia (New York, N.Y.)|June 8, 2006
ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalkYuet-Kin Leung, Ying Gao, Kin-Mang Lau, et al.
Neoplasia (New York, N.Y.)|December 17, 2013
Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12Ming-Tsung Lee, Shuk-Mei Ho, Pheruza Tarapore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2019
NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuriesTilak Khanal, Yuet-Kin Leung, Wang Jiang, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Steroids|April 3, 2012
Estrogen receptor-beta and breast cancer: translating biology into clinical practiceYuet-Kin Leung, Ming-Tsung Lee, Hung-Ming Lam, et al.
ILAR Journal|June 8, 2013
Environmental epigenetics and its implication on disease risk and health outcomesShuk-Mei Ho, Abby Johnson, Pheruza Tarapore, et al.
Pageof 8